Assignee
SYNTA PHARMACEUTICALS CORP
US·87 granted patents·69 pending applications·1,682 citations·filing 2001–2019
Top patents by PatentIndex Score
156 records- 0198US8034834B2Method for treating proliferative disorders with HSP90 inhibitorsSYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Oct 11, 2011·53 cites·15 claims
- 0298US7435843B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Oct 14, 2008·36 cites·4 claims
- 0398US7368473B2Paclitaxel enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted May 6, 2008·40 cites·23 claims
- 0497US8053456B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Nov 8, 2011·58 cites·12 claims
- 0597US7074952B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Jul 11, 2006·49 cites·25 claims
- 0697US7001923B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Feb 21, 2006·52 cites·24 claims
- 0797US6825235B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Nov 30, 2004·60 cites·60 claims
- 0896US7825148B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Nov 2, 2010·53 cites·51 claims
- 0996US7750042B2Paclitaxel enhancer compoundSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Jul 6, 2010·14 cites·32 claims
- 1096US7615552B2Fused heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Nov 10, 2009·87 cites·46 claims
- 1196US7345094B2Paclitaxel enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Mar 18, 2008·40 cites·31 claims
- 1296US7037940B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted May 2, 2006·55 cites·24 claims
- 1396US6924312B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Aug 2, 2005·58 cites·3 claims
- 1496US6800660B2Taxol enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Oct 5, 2004·71 cites·117 claims
- 1595US8835464B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Sep 16, 2014·32 cites·17 claims
- 1695US8628752B2Methods of identifying HSP90 inhibitors with less ocular toxicitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Jan 14, 2014·15 cites·8 claims
- 1795US7645904B2Purification of bis(thiohydrazide amides)SYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Jan 12, 2010·18 cites·29 claims
- 1895US7608635B2Pyrazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Oct 27, 2009·32 cites·11 claims
- 1994US7795313B2Bis(thio-hydrazide amide) salts for treatment of cancersSYNTA PHARMACEUTICALS CORP·Filed 2009·Granted Sep 14, 2010·22 cites·18 claims
- 2094US7709518B2Compounds for inflammation and immune-related usesSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted May 4, 2010·33 cites·19 claims
- 2194US7662813B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Feb 16, 2010·35 cites·35 claims
- 2294US7579503B2BIS (thio-hydrazide amide) salts for treatment of cancersSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Aug 25, 2009·23 cites·15 claims
- 2394US6660733B22,4,6-trisubstituted-pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·69 cites·25 claims
- 2493US7919487B2Heteroaryl compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Apr 5, 2011·34 cites·15 claims
- 2593US7863270B2IL-12 modulatory compoundsSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Jan 4, 2011·24 cites·4 claims
- 2693US7709683B2Synthesis of bis(thio-hydrazide amide) saltsSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted May 4, 2010·13 cites·25 claims
- 2793US7671092B2Paclitaxel enhancer compoundsSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Mar 2, 2010·16 cites·5 claims
- 2893US7067514B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Jun 27, 2006·42 cites·46 claims
- 2993US6743919B22-aroylimidazole compounds for treating cancerSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Jun 1, 2004·30 cites·66 claims
- 3093US6693097B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2001·Granted Feb 17, 2004·60 cites·39 claims
- 3192US7923557B2Process for preparing trisubstituted pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Apr 12, 2011·24 cites·8 claims
- 3292US7816535B2Vinyl-phenyl derivatives for inflammation and immune-related usesSYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Oct 19, 2010·25 cites·10 claims
- 3392US7678832B2Bis(thio-hydrazide amide) formulationSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Mar 16, 2010·18 cites·16 claims
- 3492US7652168B2Synthesis of taxol enhancersSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Jan 26, 2010·13 cites·8 claims
- 3591US6958332B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Oct 25, 2005·39 cites·32 claims
- 3690US7781462B2Compounds for the treatment of proliferative disordersSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Aug 24, 2010·5 cites·23 claims
- 3790US7745436B2Disalt inhibitors of IL-12 productionSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Jun 29, 2010·15 cites·6 claims
- 3890US7470685B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 30, 2008·11 cites·33 claims
- 3990US6680315B2Triazine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2001·Granted Jan 20, 2004·34 cites·46 claims
- 4089US8748424B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Jun 10, 2014·12 cites·3 claims
- 4189US7470681B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 30, 2008·12 cites·25 claims
- 4289US7122665B2Heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Oct 17, 2006·29 cites·28 claims
- 4389US7045517B2Triazine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted May 16, 2006·37 cites·53 claims
- 4488US9597343B2Targeted therapeuticsSYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Mar 21, 2017·4 cites·9 claims
- 4588US9206162B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2015·Granted Dec 8, 2015·6 cites·3 claims
- 4688US8937094B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Jan 20, 2015·9 cites·18 claims
- 4788US7465725B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 16, 2008·8 cites·37 claims
- 4887US9439899B2Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitorsSYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Sep 13, 2016·7 cites·17 claims
- 4987US9006277B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Apr 14, 2015·7 cites·8 claims
- 5087US8921407B2Pyrazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Dec 30, 2014·7 cites·15 claims
Showing the top 50 of 156 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →